Social impact

40 years of research on Bilharzia, the second most endemic parasite after Malaria

The start-up has been working with hard-to-reach people, based in hotspots poorly served by local health services and with a high prevalence of HBV/schistomiasis co-infection, to control morbidity and reduce avoidable deaths. The goal of all the initiatives lead by BILHI Genetics in countries with limited resources is to improve the durability ofthe population's strate of health and to participate in the economic development of countries by reducing their vulnerability and the level of poverty.

Visualize the actions carried out by BILHI Genetics

Liver damages caused by Bilharzia in Uganda, feedback from a gastroenterologist

Dr Christopher Opio is a gastroenterologist in Kampala. Many of the patients whom he treats at the hospital suffer from portal hypertension and ascites caused by Schistosoma or the hepatitis B or C virus. As the on-site doctor, he has been working with our teams along the banks of Lake Albert for several years. We would like to let him speak, in order to have a better understanding of the destruction caused by these hepatic illnesses, which affect communities in Uganda.

Bilharzia, “a silent killer”. The poignant witness of Robert K, 24-year-old, Uganda.

Robert Kabu* is a 24-year-old student from Makerere University in Kampala, Uganda. 10 years ago, he got infected by schistosomiasis in the Victoria Lake, where he used to go and play with his schoolmates. After many years of fear and pain, Robert is now cured and has decided to get involved in the fight against schistosomiasis, liver cirrhosis and varices in the region. Through his experience, he is in a better position to raise awareness about the damaging effect of schistosomiasis on the liver and the importance of prevention.
See all